|
Publication number | Application date | Organization | Virus/mechanism | Gene targets/vectors |
|
WO2017044507A2 | 2016/9/7 | Sirnaomics Inc. | MERS-CoV; siRNA | PLpro, RdRp, S protein; polymeric nanoparticle, liposomal nanoparticle |
CN102453712A | 2010/10/19 | Chinese Academy of Medical Sciences | SARS-CoV; siRNA | PI4KB; adenovirus; VeroE6 cell |
CN101597607A | 2005/3/25 | Chinese Academy of Medical Sciences | SARS-CoV; siRNA | N protein; pCMV-Myc |
CN101173275A | 2006/10/31 | Chinese Academy of Medical Sciences | SARS-CoV; siRNA | M protein |
CN101113158A | 2006/12/18 | Sichuan University | SARS-CoV; siRNA | RdRp; plasmid |
CN101085986A | 2006/6/8 | Shanghai Institutes for Biological Sciences, CAS | SARS-CoV; siRNA | ORF3a |
WO2006130855A2 | 2006/6/1 | California Institute of Technology | SARS-CoV | Recombinant retrovirus |
CN1704123A | 2004/6/1 | Guangzhou Tuopu Genetech Ltd. | SARS-CoV; siRNA | Cationic polymers, peptides |
CN1648249A | 2004/1/19 | Shanghai Institutes for Biological Sciences, CAS | SARS-CoV; siRNA | 19–25 consecutive nucleic acids on the M, N, and E genes |
US20050095618A1 | 2004/7/28 | Chinese University of Hong Kong | SARS-CoV; siRNA | S protein |
WO2005019410A2 | 2004/4/26 | Intradigm Corporation | SARS-CoV; dsRNA | nsp1, nsp9, S; aqueous glucose solution |
WO2004092383A2 | 2004/4/13 | Sirna Therapeutics, Inc. | siRNA, dsRNA, miRNA, shRNA | Chemically synthesized, modulate the expression of SARS virus RNA |
US20140294752A1 | 2014/4/1 | Research & Business FDN Sungkyunkwan Univ. | Hyaluronic acid conjugate | To deliver RNA, DNA, siRNA, aptamer, antisense oligodeoxynucleotide, antisense RNA, ribozyme, DNAzyme |
WO2014144486A2 | 2014/3/14 | Children’s Hospital of Philadelphia | Recombinant vector plasmid | Cell, viral particle, and AAV particle comprising the recombinant vector plasmid |
WO2013123503A1 | 2013/2/19 | Children’s Hospital of Philadelphia | AAV-Rh74 vector for gene transfer | AAV vector comprising a heterologous polynucleotide |
WO2010111522A2 | 2010/3/25 | University of California | Mesenchymal stem cell | For delivery of siRNA, miRNA, or dsRNA polynucleotide into a target cell |
WO2010054266A2 | 2009/11/6 | University of Washington | Multiblock copolymers | For delivery of siRNA, antisense oligonucleotide, dicer substrate, miRNA, aiRNA, shRNA, or siRNA |
|